(Q39797740)

14 September 2017

title

Mannosamine-biotin as a novel masking agent for coating IgG for immune response silencing and augmentation of antibody-antigen interaction (English)

1 reference

14 September 2017

Jacob Vaya

1

1 reference

14 September 2017

Elina Aizenshtein

2

1 reference

14 September 2017

Soliman Khatib

3

1 reference

14 September 2017

Tal Gefen

4

1 reference

14 September 2017

Michael Fassler

5

1 reference

14 September 2017

Ramadan Musa

6

1 reference

14 September 2017

Simi Krispel

7

1 reference

14 September 2017

Jacob Pitcovski

8

1 reference

14 September 2017

language of work or name

English

0 references

publication date

16 September 2009

1 reference

14 September 2017

1 reference

14 September 2017

volume

27

1 reference

14 September 2017

issue

49

1 reference

14 September 2017

page(s)

6869-6876

1 reference

Chemistry for peptide and protein PEGylation

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Disulfide bridge based PEGylation of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Treating cancer with PEG Intron: pharmacokinetic profile and dosing guidelines for an improved interferon-alpha-2b formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Structural and biologic characterization of pegylated recombinant IFN-alpha2b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Modulating pharmacokinetics of an anti-interleukin-8 F(ab')(2) by amine-specific PEGylation with preserved bioactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Reduced immunogenicity of beta-lactoglobulin by conjugation with carboxymethyl dextran differing in molecular weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Recent trends in the use of polysaccharides for improved delivery of therapeutic agents: pharmacokinetic and pharmacodynamic perspectives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Re.: Trinitrophenyl-protein conjugates are more complex than it is currently thought

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Structure-based epitope and PEGylation sites mapping of phenylalanine ammonia-lyase for enzyme substitution treatment of phenylketonuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Protein PEGylation decreases observed target association rates via a dual blocking mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

PEGylation, successful approach to drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

7 January 2021

Complex neoglycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Immunization with mannosylated peptide induces poor T cell effector functions despite enhanced antigen presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

Physicochemical characterization of poly(ethylene glycol)-modified anti-GAD antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.010

10.1016/J.VACCINE.2009.09.010

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference